Thursday, December 06, 2018 11:24:44 PM
"Updates on this * and our expansion efforts ** will be forthcoming as they develop.
*developing other certified labs (which has been talked about in every shareholder letter)
** four additional opioids (fentanyl, buprenorphine, methadone and tramadol) and quite possibly six additional benzodiazepines. This is the first time they have publicly identified which drugs they are looking to expand the panel to.
"Sweat testing for drugs of abuse can be beneficial to medical professionals in the pain management field."
If this means that PCHM's goal is to develop medical professionals in the pain management field as new customers, would these doctors be looking for drugs of abuse on a drug test that they are not prescribing?
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM